Vimarsana
Biggest News Aggregation in the World

Arvinders Soin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arvinders Soin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arvinders Soin Today - Breaking & Trending Today

Monoclonal antibodies can be gamechanger for India: Experts - Vimarsana News

Monoclonal antibodies can be gamechanger for India: Experts

Monoclonal antibody drug production in India at reasonable price could be a game changer for the country in its fight against COVID-19, said Dr Arvinder S Soi

COVID-19: Indigenous monoclonal antibodies drug's production at low cost can be 'game changer' for India, say experts - Vimarsana News

COVID-19: Indigenous monoclonal antibodies drug's production at low cost can be 'game changer' for India, say experts

New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.

Source: aninews.in
How low-cost antibody cocktail can be 'game changer' in India's Covid fight | India News - Vimarsana News

How low-cost antibody cocktail can be 'game changer' in India's Covid fight | India News

India News: NEW DELHI: Last week, an 84-year-old man from Haryana was administered the "famous" anti-Covid cocktail that was also given to former US President Don.

Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India - Vimarsana News

Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India

Date Time Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India – one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in cr...